Saturday, March 10, 2012

Lobbying by Pharmaceutical Manufacturing | OpenSecrets

Pharmaceutical Manufacturing

Pharmaceutical companies, which develop both over-the-counter and prescription drugs, have been among the biggest political spenders for years. While the industry has traditionally supported Republican candidates, some key players have recently increased donations to Democratic candidates as the GOP’s power in Washington erodes.

The pharmaceutical manufacturing industry will likely fair better this decade now that President Barack Obama’s initial plan to institute a public health insurance did not become a part of sweeping health care reform legislation signed into law in 2010. A government-run plan, because of its size, would have had considerable negotiating power to draw down drug prices. [Read more Background]

Top Contributors, 2011-2012

Pfizer Inc $702,391
Amgen Inc $574,648
AstraZeneca PLC $527,501
Abbott Laboratories $406,773
Merck & Co $363,041
GlaxoSmithKline $325,741
Eli Lilly & Co $264,762
Novartis AG $205,209
Bayer Corp $124,650
Endo Pharmaceuticals $116,400
Perrigo Co $111,475
Mutual Pharmaceutical $105,000
Allergan Inc $88,000
Teva Pharmaceuticals USA $86,870
Sanofi-Aventis $78,300
Bristol-Myers Squibb $70,050
Pharmaceutical Rsrch & Mfrs of America $65,450
Nostrum Pharmaceuticals $62,300
Cephalon Inc $61,250
Takeda Pharmaceuticals North America $61,250

...view more Contributors

Contribution Trends, 1990-2010

...view Totals

Lobbying Totals, 1998-2010

...view more Lobbying

Party Split, 1990-2010

Top Recipients, 2011-2012

Obama, Barack (D) $129,139
Romney, Mitt (R) $89,300
Upton, Fred (R-MI)House $77,575
Brown, Scott P (R-MA)Senate $76,483
Hatch, Orrin G (R-UT)Senate $69,400

...view more Recipients

Average Contributions to Members of Congress, 1990-2010 About this chart

Data for the current election cycle were released by the Federal Election Commission on Monday, February 13, 2012

Feel free to distribute or cite this material, but please credit the Center for Responsive Politics.

Posted via email from Jack's posterous

No comments: